PANTOPRAZOLE

PANTOPRAZOLE was reported 256974 times

PANTOPRAZOLE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DEEP VEIN THROMBOSIS POSTOPERATIVE 1122 0.5602
1 LUPUS VULGARIS 673 0.5341
2 C-REACTIVE PROTEIN 473 0.5102
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 325 0.4865
4 SWOLLEN JOINT COUNT INCREASED 1547 0.4846
5 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 893 0.4306
6 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 3071 0.4282
7 DUODENAL ULCER PERFORATION 3117 0.4187
8 RHEUMATIC FEVER 1826 0.4092
9 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 228 0.4064
10 X-RAY ABNORMAL 710 0.3966
11 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2513 0.3866
12 MUSCLE INJURY 3206 0.3865
13 DISLOCATION OF VERTEBRA 868 0.3802
14 FACET JOINT SYNDROME 1201 0.3685
15 RHEUMATOID FACTOR POSITIVE 1974 0.3414
16 RETINITIS 569 0.3291
17 HELICOBACTER INFECTION 3324 0.3231
18 FOLLICULITIS 3375 0.3215
19 PEMPHIGUS 3953 0.3159
20 PERIPHERAL VENOUS DISEASE 1182 0.2891
21 HAND DEFORMITY 3625 0.2761
22 SYSTEMIC INFECTION 457 0.2755
23 HYPERTENSIVE NEPHROPATHY 277 0.2596
24 BLOOD PRESSURE DIASTOLIC ABNORMAL 639 0.2510
25 BLOOD PRESSURE SYSTOLIC ABNORMAL 570 0.2304
26 PERICARDITIS 3725 0.2215
27 PORPHYRIA ACUTE 316 0.2202
28 SYNOVITIS 3903 0.2162
29 C-REACTIVE PROTEIN ABNORMAL 1381 0.2151
30 SERONEGATIVE ARTHRITIS 244 0.2129
31 BONE EROSION 710 0.2006
32 DRUG TOLERANCE DECREASED 529 0.1882
33 NEPHROGENIC ANAEMIA 836 0.1803
34 GLOSSODYNIA 4038 0.1802
35 ADJUSTMENT DISORDER 234 0.1800
36 TEMPERATURE REGULATION DISORDER 398 0.1785
37 PRODUCT MONITORING ERROR 257 0.1779
38 IRRITABLE BOWEL SYNDROME 3719 0.1733
39 END STAGE RENAL DISEASE 2907 0.1592
40 BURSITIS 1906 0.1569
41 HYPERCHOLESTEROLAEMIA 1433 0.1483
42 FEMALE GENITAL TRACT FISTULA 251 0.1469
43 BREAST CANCER STAGE III 944 0.1456
44 WOUND 4026 0.1439
45 LIP DRY 1304 0.1434
46 CONTRAINDICATED PRODUCT ADMINISTERED 4230 0.1396
47 CHRONIC KIDNEY DISEASE 10608 0.1395
48 CHRONIC SINUSITIS 523 0.1392
49 HYPERPARATHYROIDISM SECONDARY 349 0.1392
50 REBOUND ACID HYPERSECRETION 412 0.1361
51 NEURITIS 206 0.1333
52 JOINT RANGE OF MOTION DECREASED 1786 0.1330
53 WOUND INFECTION 1458 0.1330
54 AUTOIMMUNE DISORDER 1287 0.1319
55 DIABETIC NEPHROPATHY 289 0.1312
56 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 295 0.1279
57 CLOSTRIDIUM TEST POSITIVE 275 0.1246
58 GRIP STRENGTH DECREASED 1094 0.1242
59 IMPAIRED HEALING 4053 0.1233
60 HYPOMAGNESAEMIA 1665 0.1195
61 SYSTEMIC LUPUS ERYTHEMATOSUS 4240 0.1193
62 AORTIC VALVE STENOSIS 211 0.1182
63 DIASTOLIC DYSFUNCTION 359 0.1162
64 RESPIRATORY SYMPTOM 327 0.1149
65 INFUSION SITE REACTION 337 0.1127
66 OBSTRUCTIVE AIRWAYS DISORDER 1228 0.1103
67 BLEPHAROSPASM 693 0.1099
68 FIBROMYALGIA 2663 0.1094
69 LIVER INJURY 2669 0.1086
70 PULMONARY FIBROSIS 2028 0.1056
71 LOWER RESPIRATORY TRACT INFECTION 4644 0.1020
72 LIVE BIRTH 846 0.1010
73 MATERNAL EXPOSURE TIMING UNSPECIFIED 374 0.0995
74 RADICULOPATHY 252 0.0955
75 OBESITY 1502 0.0942
76 FORCED EXPIRATORY VOLUME DECREASED 262 0.0924
77 PROCTITIS 259 0.0924
78 FULL BLOOD COUNT ABNORMAL 970 0.0916
79 BREATH SOUNDS ABNORMAL 450 0.0912
80 SCIATICA 1450 0.0909
81 BLOOD PRESSURE DIASTOLIC DECREASED 669 0.0905
82 PLEURITIC PAIN 249 0.0901
83 BENIGN PROSTATIC HYPERPLASIA 454 0.0878
84 ARTHROPATHY 4855 0.0873
85 PRESCRIBED OVERDOSE 1689 0.0872
86 EXOSTOSIS 795 0.0870
87 BLOOD PRESSURE SYSTOLIC INCREASED 1685 0.0863
88 WALKING AID USER 567 0.0859
89 RED BLOOD CELL SEDIMENTATION RATE INCREASED 936 0.0845
90 PERSONALITY DISORDER 219 0.0835
91 MUSCLE SPASTICITY 1014 0.0824
92 INFUSION RELATED REACTION 5454 0.0822
93 THERAPEUTIC PRODUCT EFFECT DECREASED 3664 0.0817
94 ULCER HAEMORRHAGE 553 0.0816
95 TUBULOINTERSTITIAL NEPHRITIS 1521 0.0811
96 TYPE 2 DIABETES MELLITUS 2724 0.0808
97 PSORIATIC ARTHROPATHY 3284 0.0808
98 BODY TEMPERATURE DECREASED 796 0.0808
99 BRONCHIECTASIS 542 0.0804
100 FOOD ALLERGY 620 0.0802
101 THERAPEUTIC REACTION TIME DECREASED 232 0.0795
102 PUSTULAR PSORIASIS 269 0.0782
103 HEPATIC ENZYME INCREASED 5260 0.0771
104 DIVERTICULUM INTESTINAL 337 0.0770
105 ACUTE KIDNEY INJURY 11771 0.0768
106 HYPOCALCAEMIA 1444 0.0762
107 RENAL CYST 604 0.0760
108 STOMATITIS 4605 0.0759
109 BLISTER 4250 0.0756
110 NIGHT SWEATS 2397 0.0743
111 VITAMIN B12 DECREASED 214 0.0742
112 LOWER LIMB FRACTURE 1424 0.0740
113 C-REACTIVE PROTEIN INCREASED 2670 0.0733
114 NORMOCHROMIC NORMOCYTIC ANAEMIA 220 0.0732
115 SPINAL STENOSIS 296 0.0716
116 SPUTUM DISCOLOURED 676 0.0712
117 NEPHROPATHY 660 0.0706
118 WHEEZING 4188 0.0706
119 RENAL INJURY 2090 0.0703
120 RALES 406 0.0698
121 LUPUS-LIKE SYNDROME 633 0.0697
122 FOOT DEFORMITY 770 0.0694
123 GENERAL PHYSICAL HEALTH DETERIORATION 8011 0.0692
124 OSTEOARTHRITIS 2920 0.0688
125 ONYCHOMADESIS 289 0.0688
126 CREPITATIONS 205 0.0688
127 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 608 0.0687
128 PNEUMONIA VIRAL 217 0.0680
129 EAR PAIN 1310 0.0673
130 MACULAR DEGENERATION 791 0.0662
131 DISCOMFORT 4036 0.0661
132 BLOOD PRESSURE DIASTOLIC INCREASED 305 0.0660
133 IRON DEFICIENCY 297 0.0660
134 IMMUNODEFICIENCY 949 0.0636
135 BREAST CANCER STAGE II 528 0.0634
136 RASH VESICULAR 304 0.0628
137 LEFT VENTRICULAR HYPERTROPHY 268 0.0626
138 HIP ARTHROPLASTY 959 0.0626
139 HEPATITIS CHOLESTATIC 377 0.0625
140 RED CELL DISTRIBUTION WIDTH INCREASED 260 0.0625
141 BLOOD PRESSURE FLUCTUATION 1494 0.0622
142 ERYSIPELAS 311 0.0618
143 IRON DEFICIENCY ANAEMIA 564 0.0610
144 SPONDYLITIS 221 0.0607
145 SWELLING 5688 0.0607
146 OBSTRUCTION 242 0.0605
147 JOINT DISLOCATION 638 0.0603
148 TASTE DISORDER 1222 0.0602
149 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1019 0.0599
150 RHEUMATOID ARTHRITIS 6812 0.0599
151 GAIT INABILITY 1985 0.0593
152 GASTROOESOPHAGEAL REFLUX DISEASE 4754 0.0590
153 JOINT SWELLING 7102 0.0588
154 BODY TEMPERATURE INCREASED 1200 0.0588
155 PRESCRIBED UNDERDOSE 1168 0.0585
156 EOSINOPHILIA 1025 0.0584
157 BLOOD CHOLESTEROL INCREASED 2715 0.0582
158 FOETAL DEATH 301 0.0580
159 SINUSITIS 5940 0.0579
160 HEPATIC CIRRHOSIS 1078 0.0573
161 TRICUSPID VALVE INCOMPETENCE 454 0.0571
162 MONOCYTE COUNT INCREASED 207 0.0569
163 VITAMIN B12 DEFICIENCY 230 0.0567
164 CLOSTRIDIUM DIFFICILE COLITIS 601 0.0566
165 LUNG DISORDER 2777 0.0566
166 DRUG INTOLERANCE 5473 0.0566
167 HYPOKALAEMIA 2593 0.0561
168 ELECTROLYTE IMBALANCE 651 0.0560
169 SHOCK HAEMORRHAGIC 454 0.0557
170 GASTROINTESTINAL DISORDER 4976 0.0555
171 CHOLESTASIS 1066 0.0555
172 VASCULAR DEVICE INFECTION 247 0.0544
173 GASTRITIS EROSIVE 253 0.0542
174 ILL-DEFINED DISORDER 3284 0.0540
175 TROPONIN INCREASED 409 0.0537
176 IMPAIRED GASTRIC EMPTYING 732 0.0536
177 ESCHERICHIA URINARY TRACT INFECTION 228 0.0536
178 DYSPNOEA EXERTIONAL 2018 0.0535
179 DELIRIUM 1854 0.0534
180 AGRANULOCYTOSIS 986 0.0530
181 COELIAC DISEASE 520 0.0530
182 RENAL TUBULAR NECROSIS 515 0.0524
183 POOR VENOUS ACCESS 542 0.0523
184 APHTHOUS ULCER 404 0.0520
185 FAECALOMA 283 0.0516
186 HIATUS HERNIA 668 0.0515
187 CACHEXIA 264 0.0513
188 FREQUENT BOWEL MOVEMENTS 1382 0.0511
189 HYPONATRAEMIA 2878 0.0510
190 MUSCULOSKELETAL PAIN 2661 0.0507
191 COLITIS MICROSCOPIC 240 0.0506
192 NAIL DISORDER 442 0.0505
193 PERIPHERAL SWELLING 7763 0.0503
194 MELAENA 1106 0.0502
195 UROSEPSIS 462 0.0500
196 CONTUSION 4820 0.0500
197 AORTIC VALVE INCOMPETENCE 213 0.0500
198 ARTERIOSCLEROSIS CORONARY ARTERY 329 0.0496
199 RESPIRATORY DISORDER 1484 0.0496
200 HEPATIC CYTOLYSIS 632 0.0495
201 TOXIC EPIDERMAL NECROLYSIS 750 0.0493
202 OEDEMA 2676 0.0493
203 NEUROLOGICAL SYMPTOM 281 0.0491
204 EXERCISE TOLERANCE DECREASED 280 0.0486
205 INTENTIONAL PRODUCT USE ISSUE 4257 0.0485
206 BACK INJURY 528 0.0485
207 VASCULITIS 564 0.0484
208 MITRAL VALVE INCOMPETENCE 547 0.0483
209 PRODUCTIVE COUGH 2306 0.0483
210 UPPER GASTROINTESTINAL HAEMORRHAGE 811 0.0482
211 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2313 0.0481
212 BLOOD MAGNESIUM DECREASED 415 0.0480
213 ATELECTASIS 464 0.0480
214 JOINT EFFUSION 331 0.0480
215 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 243 0.0479
216 FAECES SOFT 349 0.0479
217 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 490 0.0477
218 SLEEP DISORDER 3366 0.0476
219 INFLAMMATORY MARKER INCREASED 236 0.0476
220 ORAL CANDIDIASIS 624 0.0473
221 MOBILITY DECREASED 3387 0.0471
222 MYOSITIS 422 0.0470
223 KNEE ARTHROPLASTY 989 0.0469
224 ASTHMA 5284 0.0467
225 LIVER FUNCTION TEST INCREASED 1001 0.0466
226 LEFT VENTRICULAR DYSFUNCTION 312 0.0465
227 GASTRITIS 1220 0.0463
228 RASH MACULO-PAPULAR 1028 0.0462
229 HYPOVOLAEMIC SHOCK 221 0.0461
230 SPINAL OSTEOARTHRITIS 405 0.0461
231 SUSPECTED OFF LABEL USE 208 0.0460
232 FEBRILE NEUTROPENIA 3054 0.0460
233 SKIN ABRASION 217 0.0459
234 LIVER DISORDER 2023 0.0456
235 NASAL POLYPS 223 0.0452
236 GANGRENE 272 0.0451
237 HYPERVOLAEMIA 223 0.0451
238 MUSCULOSKELETAL STIFFNESS 3935 0.0449
239 GLOMERULAR FILTRATION RATE DECREASED 550 0.0447
240 RENAL FAILURE 5932 0.0446
241 MUCOUS STOOLS 221 0.0446
242 PULMONARY ALVEOLAR HAEMORRHAGE 250 0.0445
243 HAEMATOCHEZIA 2456 0.0445
244 INFUSION SITE SWELLING 279 0.0443
245 ARTERIOSCLEROSIS 417 0.0443
246 DYSLIPIDAEMIA 225 0.0443
247 LOWER GASTROINTESTINAL HAEMORRHAGE 327 0.0442
248 ARTERIAL OCCLUSIVE DISEASE 347 0.0441
249 HEART RATE DECREASED 1546 0.0440
250 HEPATIC STEATOSIS 816 0.0438
251 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 751 0.0438
252 OESOPHAGITIS 476 0.0435
253 INFECTION 6293 0.0434
254 OSTEOPOROSIS 1785 0.0434
255 ANAL FISSURE 232 0.0432
256 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 336 0.0432
257 CONFUSIONAL STATE 6982 0.0432
258 ANAL INCONTINENCE 388 0.0431
259 GASTRIC ULCER 817 0.0429
260 RESPIRATORY RATE INCREASED 381 0.0429
261 DRUG TOLERANCE 217 0.0429
262 LARGE INTESTINE POLYP 297 0.0428
263 RECTAL HAEMORRHAGE 1840 0.0428
264 BLOOD IRON DECREASED 506 0.0426
265 HYPERKALAEMIA 1494 0.0426
266 FLUID INTAKE REDUCED 213 0.0425
267 OXYGEN SATURATION DECREASED 2389 0.0425
268 INFLAMMATION 2168 0.0420
269 ABNORMAL FAECES 344 0.0419
270 SEASONAL ALLERGY 594 0.0419
271 ABDOMINAL DISCOMFORT 7036 0.0419
272 BLOOD URIC ACID INCREASED 242 0.0419
273 UPPER RESPIRATORY TRACT INFECTION 1928 0.0417
274 CLOSTRIDIUM DIFFICILE INFECTION 903 0.0413
275 HYPOVOLAEMIA 242 0.0413
276 INTERVERTEBRAL DISC DEGENERATION 382 0.0412
277 COVID-19 PNEUMONIA 487 0.0412
278 HAEMATOCRIT DECREASED 816 0.0411
279 TENDERNESS 428 0.0410
280 FLANK PAIN 379 0.0404
281 DRUG LEVEL BELOW THERAPEUTIC 223 0.0404
282 CYTOKINE RELEASE SYNDROME 809 0.0403
283 ENTERITIS 258 0.0403
284 POLYNEUROPATHY 482 0.0402
285 HYPERTRANSAMINASAEMIA 279 0.0401
286 WEIGHT FLUCTUATION 419 0.0400
287 HEPATOCELLULAR INJURY 567 0.0400
288 JOINT STIFFNESS 1049 0.0399
289 HAEMATEMESIS 1012 0.0399
290 PRODUCT PRESCRIBING ERROR 949 0.0398
291 ANAEMIA 7572 0.0397
292 DYSPEPSIA 3900 0.0396
293 TRANSFUSION 415 0.0396
294 POLYURIA 324 0.0395
295 NOCTURIA 480 0.0395
296 POLYARTHRITIS 208 0.0394
297 ROAD TRAFFIC ACCIDENT 1644 0.0393
298 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1011 0.0393
299 ACUTE RESPIRATORY FAILURE 755 0.0392
300 LEUKOPENIA 1959 0.0391
301 INFUSION SITE ERYTHEMA 330 0.0391
302 GAMMA-GLUTAMYLTRANSFERASE INCREASED 867 0.0391
303 BLOOD ALBUMIN DECREASED 310 0.0390
304 SENSORY LOSS 313 0.0388
305 TOXIC SKIN ERUPTION 391 0.0388
306 NASOPHARYNGITIS 7108 0.0385
307 ATRIAL FLUTTER 306 0.0383
308 EPILEPSY 1172 0.0383
309 MATERNAL EXPOSURE DURING PREGNANCY 3397 0.0381
310 HYPOPHOSPHATAEMIA 280 0.0378
311 ON AND OFF PHENOMENON 210 0.0378
312 HYDRONEPHROSIS 282 0.0376
313 TREATMENT FAILURE 3107 0.0375
314 HAEMATURIA 1284 0.0375
315 HAEMORRHOIDS 728 0.0373
316 ANGINA PECTORIS 1069 0.0373
317 ULCER 593 0.0372
318 PULMONARY MASS 555 0.0372
319 EAR INFECTION 990 0.0372
320 ESCHERICHIA INFECTION 306 0.0372
321 PYELONEPHRITIS 321 0.0370
322 PANCYTOPENIA 2066 0.0369
323 DRY MOUTH 2999 0.0369
324 LIPASE INCREASED 283 0.0369
325 NODULE 482 0.0369
326 POSTOPERATIVE WOUND INFECTION 249 0.0368
327 THERAPY NON-RESPONDER 1656 0.0368
328 COLITIS ULCERATIVE 1645 0.0368
329 GOUT 660 0.0367
330 OEDEMA PERIPHERAL 4483 0.0367
331 HYPERSENSITIVITY 6813 0.0367
332 SEPTIC SHOCK 1596 0.0366
333 RIGHT VENTRICULAR FAILURE 257 0.0366
334 GASTROENTERITIS 532 0.0364
335 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2583 0.0363
336 HYPERTENSION 7690 0.0363
337 SINUS CONGESTION 490 0.0362
338 HAEMOPTYSIS 1011 0.0362
339 RED BLOOD CELL COUNT DECREASED 1035 0.0362
340 POLYP 237 0.0362
341 SMALL INTESTINAL OBSTRUCTION 444 0.0360
342 ASPIRATION 393 0.0358
343 HAEMATOMA 929 0.0358
344 ABDOMINAL PAIN 8321 0.0357
345 DRUG LEVEL DECREASED 364 0.0357
346 SLEEP APNOEA SYNDROME 680 0.0356
347 HYPOXIA 1252 0.0355
348 THROMBOCYTOPENIA 3971 0.0355
349 ABDOMINAL PAIN UPPER 7304 0.0354
350 OLIGURIA 220 0.0354
351 RESPIRATORY TRACT CONGESTION 562 0.0353
352 RHINITIS 285 0.0353
353 DUODENAL ULCER 249 0.0353
354 ACUTE CORONARY SYNDROME 292 0.0352
355 TACHYPNOEA 479 0.0352
356 RESPIRATORY TRACT INFECTION 915 0.0351
357 SQUAMOUS CELL CARCINOMA OF SKIN 212 0.0351
358 DIALYSIS 498 0.0351
359 MICTURITION URGENCY 400 0.0350
360 ATRIAL FIBRILLATION 3410 0.0350
361 DEFAECATION URGENCY 245 0.0349
362 FLUID RETENTION 1778 0.0349
363 WEIGHT INCREASED 7817 0.0349
364 DIVERTICULUM 248 0.0349
365 HEMIPLEGIA 290 0.0348
366 INJURY 2442 0.0347
367 DRUG INTERACTION 5507 0.0347
368 RENAL IMPAIRMENT 2905 0.0345
369 COLITIS 1307 0.0344
370 CYSTITIS 1096 0.0344
371 INFUSION SITE PAIN 442 0.0343
372 DRUG-INDUCED LIVER INJURY 1074 0.0342
373 PREGNANCY 684 0.0341
374 LYMPHOEDEMA 236 0.0341
375 PYREXIA 11802 0.0341
376 HYPOTHYROIDISM 1086 0.0340
377 HEPATITIS ACUTE 221 0.0340
378 DECUBITUS ULCER 277 0.0340
379 HYPERLIPIDAEMIA 406 0.0339
380 LACTIC ACIDOSIS 1099 0.0339
381 ILEUS 419 0.0337
382 PNEUMONIA 10915 0.0337
383 PANCREATITIS ACUTE 756 0.0336
384 CARDIAC FAILURE ACUTE 224 0.0336
385 HYPERTENSIVE CRISIS 374 0.0336
386 PROTEINURIA 632 0.0332
387 VITAMIN D DEFICIENCY 324 0.0332
388 UPPER-AIRWAY COUGH SYNDROME 273 0.0331
389 ATRIOVENTRICULAR BLOCK 256 0.0331
390 NEUTROPHIL COUNT INCREASED 339 0.0331
391 DYSURIA 1218 0.0331
392 HAEMOGLOBIN DECREASED 3392 0.0330
393 SECRETION DISCHARGE 413 0.0329
394 MYOCLONUS 393 0.0329
395 PLEURAL EFFUSION 2005 0.0329
396 BLOOD CREATININE INCREASED 2148 0.0329
397 CANDIDA INFECTION 555 0.0328
398 PRESYNCOPE 798 0.0328
399 MALNUTRITION 367 0.0328
400 HYPERCALCAEMIA 405 0.0328
401 ARTHRITIS 2578 0.0327
402 ANKYLOSING SPONDYLITIS 431 0.0327
403 HEMIPARESIS 552 0.0326
404 PARAESTHESIA ORAL 470 0.0325
405 SKIN LACERATION 354 0.0325
406 GASTROINTESTINAL PAIN 358 0.0325
407 TRANSAMINASES INCREASED 714 0.0321
408 BLOOD PRESSURE INCREASED 4904 0.0320
409 EJECTION FRACTION DECREASED 498 0.0320
410 GASTROINTESTINAL INFLAMMATION 251 0.0320
411 ATRIOVENTRICULAR BLOCK COMPLETE 214 0.0319
412 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1668 0.0319
413 MOTOR DYSFUNCTION 324 0.0318
414 CARDIAC FAILURE 2545 0.0317
415 CHEST PAIN 5852 0.0316
416 SINUS DISORDER 625 0.0315
417 DIVERTICULITIS 874 0.0315
418 ACUTE MYOCARDIAL INFARCTION 930 0.0315
419 MUCOSAL INFLAMMATION 825 0.0315
420 DECREASED APPETITE 7315 0.0315
421 BACK DISORDER 512 0.0315
422 BLOOD TEST ABNORMAL 442 0.0314
423 PURPURA 278 0.0314
424 ELECTROCARDIOGRAM ABNORMAL 246 0.0313
425 FAECES DISCOLOURED 678 0.0312
426 HEPATIC ENCEPHALOPATHY 291 0.0312
427 HYPOALBUMINAEMIA 242 0.0311
428 VITAMIN D DECREASED 266 0.0311
429 DYSPNOEA 17581 0.0310
430 ASTHENIA 11658 0.0310
431 BRONCHITIS 2294 0.0310
432 CONDITION AGGRAVATED 9403 0.0309
433 MIDDLE INSOMNIA 577 0.0309
434 HYPERBILIRUBINAEMIA 320 0.0309
435 BLOOD CALCIUM DECREASED 347 0.0308
436 SPINAL PAIN 361 0.0308
437 CARDIOGENIC SHOCK 442 0.0308
438 RHABDOMYOLYSIS 1284 0.0308
439 VENTRICULAR EXTRASYSTOLES 319 0.0307
440 OSTEOPENIA 466 0.0307
441 HYPOPHAGIA 785 0.0307
442 GASTROINTESTINAL HAEMORRHAGE 2566 0.0307
443 HEPATITIS 785 0.0306
444 INTERVERTEBRAL DISC PROTRUSION 670 0.0306
445 GENERALISED OEDEMA 379 0.0306
446 BRADYCARDIA 1624 0.0306
447 INTESTINAL OBSTRUCTION 1153 0.0306
448 ALOPECIA 6006 0.0306
449 ORTHOSTATIC HYPOTENSION 532 0.0305
450 DIARRHOEA HAEMORRHAGIC 285 0.0305
451 GASTROINTESTINAL INFECTION 273 0.0304
452 EMPHYSEMA 307 0.0304
453 WEIGHT DECREASED 8471 0.0303
454 SKIN LESION 832 0.0303
455 BLOOD CALCIUM INCREASED 266 0.0303
456 ADRENAL INSUFFICIENCY 367 0.0302
457 CYST 375 0.0302
458 BOWEL MOVEMENT IRREGULARITY 231 0.0301
459 CHOLECYSTITIS 359 0.0301
460 WHITE BLOOD CELL COUNT INCREASED 1155 0.0301
461 MUSCULAR WEAKNESS 3421 0.0301
462 COLITIS ISCHAEMIC 203 0.0301
463 GROIN PAIN 264 0.0300
464 SOPOR 398 0.0300
465 ARTHRALGIA 12489 0.0300
466 SUPRAVENTRICULAR TACHYCARDIA 287 0.0299
467 HYPOTENSION 6007 0.0299
468 LYMPHOCYTE COUNT DECREASED 529 0.0299
469 HEPATOMEGALY 292 0.0297
470 CORONARY ARTERY DISEASE 899 0.0297
471 HOSPICE CARE 293 0.0296
472 GENERAL SYMPTOM 222 0.0296
473 SPLENOMEGALY 346 0.0295
474 BLOOD SODIUM DECREASED 553 0.0293
475 BLOOD POTASSIUM DECREASED 882 0.0293
476 ASCITES 860 0.0292
477 METABOLIC ACIDOSIS 934 0.0292
478 EXPOSURE DURING PREGNANCY 1815 0.0292
479 RESPIRATORY SYNCYTIAL VIRUS INFECTION 253 0.0290
480 INTERNAL HAEMORRHAGE 332 0.0290
481 ANURIA 250 0.0290
482 PALLOR 790 0.0290
483 DEHYDRATION 3872 0.0290
484 CIRCULATORY COLLAPSE 494 0.0290
485 SEPSIS 3232 0.0289
486 BLOOD UREA INCREASED 485 0.0289
487 PULMONARY HYPERTENSION 603 0.0289
488 ENCEPHALOPATHY 710 0.0289
489 ELECTROCARDIOGRAM QT PROLONGED 1038 0.0288
490 POST PROCEDURAL INFECTION 234 0.0287
491 DISABILITY 569 0.0287
492 LUNG INFILTRATION 254 0.0287
493 DIZZINESS POSTURAL 277 0.0285
494 MIGRAINE 2725 0.0285
495 VENTRICULAR TACHYCARDIA 471 0.0285
496 EOSINOPHIL COUNT INCREASED 237 0.0284
497 KIDNEY INFECTION 558 0.0284
498 MUSCULOSKELETAL CHEST PAIN 440 0.0284
499 PANCREATITIS 1502 0.0284
500 RIB FRACTURE 583 0.0283
501 HEART RATE IRREGULAR 640 0.0283
502 LYMPHOPENIA 400 0.0283
503 PETECHIAE 295 0.0282
504 BLOOD POTASSIUM INCREASED 458 0.0282
505 MULTIPLE ORGAN DYSFUNCTION SYNDROME 799 0.0282
506 PERICARDIAL EFFUSION 652 0.0282
507 AFFECT LABILITY 271 0.0281
508 BASAL CELL CARCINOMA 439 0.0281
509 LIGAMENT SPRAIN 277 0.0280
510 HYPOAESTHESIA 4189 0.0280
511 BLOOD COUNT ABNORMAL 422 0.0278
512 DIARRHOEA 17955 0.0278
513 INTERNATIONAL NORMALISED RATIO INCREASED 793 0.0278
514 VOMITING 13065 0.0278
515 URINARY TRACT INFECTION 4733 0.0277
516 BLOOD ALKALINE PHOSPHATASE INCREASED 689 0.0277
517 PELVIC FRACTURE 216 0.0277
518 GASTRIC HAEMORRHAGE 319 0.0277
519 CONSTIPATION 6044 0.0277
520 RENAL PAIN 293 0.0276
521 LEUKOCYTOSIS 500 0.0276
522 CHOLELITHIASIS 906 0.0276
523 MYASTHENIA GRAVIS 223 0.0276
524 SKIN HAEMORRHAGE 409 0.0276
525 TOOTH INFECTION 363 0.0275
526 SINUS TACHYCARDIA 391 0.0275
527 PSEUDOMONAS INFECTION 236 0.0275
528 PRODUCT ADMINISTRATION INTERRUPTED 216 0.0275
529 URINARY RETENTION 917 0.0275
530 HAEMOLYTIC ANAEMIA 246 0.0274
531 PLATELET COUNT INCREASED 357 0.0274
532 URTICARIA 4572 0.0273
533 CONGENITAL ANOMALY 211 0.0272
534 CARDIOMEGALY 335 0.0272
535 FATIGUE 21188 0.0272
536 FALL 9040 0.0271
537 SKIN ULCER 702 0.0271
538 EATING DISORDER 578 0.0271
539 NEPHROLITHIASIS 1245 0.0271
540 SUBDURAL HAEMATOMA 388 0.0271
541 MYOPATHY 234 0.0271
542 SYNCOPE 2710 0.0271
543 COUGH 7579 0.0270
544 PNEUMONITIS 735 0.0270
545 APHASIA 814 0.0269
546 ABDOMINAL PAIN LOWER 681 0.0269
547 URINARY INCONTINENCE 794 0.0268
548 ABSCESS 426 0.0267
549 BLOOD BILIRUBIN INCREASED 721 0.0267
550 BACTERAEMIA 315 0.0265
551 ORAL PAIN 594 0.0265
552 AMNESIA 1717 0.0264
553 HYPOGLYCAEMIA 1280 0.0264
554 PULMONARY CONGESTION 347 0.0263
555 RESPIRATORY FAILURE 1918 0.0263
556 BLOOD LACTATE DEHYDROGENASE INCREASED 416 0.0262
557 CHEST DISCOMFORT 2678 0.0261
558 BACK PAIN 6073 0.0261
559 JAUNDICE 702 0.0261
560 DYSPHAGIA 2466 0.0260
561 RHINORRHOEA 1678 0.0259
562 LIMB INJURY 703 0.0259
563 DYSPHONIA 1510 0.0258
564 FLATULENCE 1462 0.0258
565 NEPHROPATHY TOXIC 289 0.0257
566 TACHYCARDIA 2287 0.0257
567 PRODUCT USE ISSUE 4836 0.0257
568 PAIN 15803 0.0257
569 HYPERTHYROIDISM 372 0.0257
570 PNEUMOCYSTIS JIROVECII PNEUMONIA 258 0.0257
571 HYPOKINESIA 373 0.0257
572 ORAL HERPES 501 0.0256
573 EPISTAXIS 1917 0.0256
574 NEURALGIA 623 0.0256
575 DYSARTHRIA 955 0.0253
576 NECK PAIN 1416 0.0253
577 COORDINATION ABNORMAL 353 0.0253
578 LOCALISED INFECTION 611 0.0252
579 VAGINAL DISCHARGE 255 0.0252
580 MYOCARDIAL ISCHAEMIA 286 0.0251
581 CATARACT 1496 0.0251
582 PULMONARY ARTERIAL HYPERTENSION 364 0.0251
583 RASH ERYTHEMATOUS 1199 0.0251
584 NERVE COMPRESSION 231 0.0250
585 PULMONARY EMBOLISM 2378 0.0250
586 DEVICE RELATED INFECTION 385 0.0250
587 HAEMODIALYSIS 210 0.0250
588 MEDICATION ERROR 1389 0.0250
589 PAIN IN EXTREMITY 7345 0.0249
590 GAIT DISTURBANCE 4755 0.0248
591 ALANINE AMINOTRANSFERASE INCREASED 1524 0.0248
592 FEEDING DISORDER 503 0.0248
593 OROPHARYNGEAL PAIN 2292 0.0247
594 HALLUCINATION, VISUAL 522 0.0247
595 URINE OUTPUT DECREASED 216 0.0247
596 ABDOMINAL DISTENSION 2578 0.0247
597 RASH 10756 0.0246
598 HYPERGLYCAEMIA 898 0.0246
599 HEART RATE INCREASED 2438 0.0246
600 LIMB DISCOMFORT 761 0.0246
601 HERNIA 473 0.0244
602 ISCHAEMIC STROKE 436 0.0244
603 HYPOTHERMIA 247 0.0244
604 CORONARY ARTERY OCCLUSION 333 0.0243
605 INFLUENZA 2703 0.0242
606 ARRHYTHMIA 1146 0.0242
607 CONJUNCTIVITIS 448 0.0241
608 BLOOD PRESSURE ABNORMAL 478 0.0240
609 FISTULA 270 0.0240
610 MEMORY IMPAIRMENT 3293 0.0239
611 TOOTH ABSCESS 244 0.0239
612 INCONTINENCE 253 0.0239
613 PRURITUS 9195 0.0239
614 SUBARACHNOID HAEMORRHAGE 243 0.0238
615 PULMONARY OEDEMA 1067 0.0238
616 MUSCLE SPASMS 4365 0.0238
617 DRUG LEVEL INCREASED 393 0.0237
618 PHOTOSENSITIVITY REACTION 392 0.0237
619 SKIN INFECTION 266 0.0237
620 SINUS BRADYCARDIA 229 0.0237
621 GASTROENTERITIS VIRAL 427 0.0236
622 RETCHING 501 0.0235
623 WRIST FRACTURE 281 0.0234
624 BLOOD PRESSURE DECREASED 1554 0.0234
625 HERPES ZOSTER 1335 0.0232
626 PARAESTHESIA 3653 0.0232
627 FEELING COLD 645 0.0231
628 IMPAIRED QUALITY OF LIFE 333 0.0231
629 ASPARTATE AMINOTRANSFERASE INCREASED 1230 0.0231
630 INCREASED TENDENCY TO BRUISE 213 0.0231
631 DERMATITIS ALLERGIC 291 0.0231
632 SNEEZING 518 0.0231
633 NAUSEA 18251 0.0230
634 PHARYNGITIS 286 0.0230
635 ROTATOR CUFF SYNDROME 296 0.0230
636 NASAL CONGESTION 1351 0.0230
637 PNEUMONIA BACTERIAL 211 0.0230
638 INTESTINAL PERFORATION 258 0.0230
639 BACTERIAL INFECTION 428 0.0229
640 SPINAL DISORDER 217 0.0229
641 DISORIENTATION 901 0.0227
642 COVID-19 3982 0.0227
643 PHARYNGEAL SWELLING 222 0.0227
644 MOUTH ULCERATION 478 0.0227
645 MYOCARDITIS 260 0.0227
646 FOOT FRACTURE 430 0.0227
647 RESPIRATORY DISTRESS 625 0.0226
648 RESTLESSNESS 828 0.0226
649 HEPATIC FAILURE 681 0.0226
650 JOINT INJURY 482 0.0225
651 TRANSIENT ISCHAEMIC ATTACK 761 0.0225
652 NEUTROPENIA 3065 0.0225
653 ACUTE HEPATIC FAILURE 308 0.0225
654 PNEUMONIA ASPIRATION 563 0.0225
655 RASH PRURITIC 1220 0.0225
656 HEPATOTOXICITY 501 0.0225
657 BLOOD CREATINE PHOSPHOKINASE INCREASED 647 0.0225
658 FULL BLOOD COUNT DECREASED 451 0.0224
659 DIZZINESS 11146 0.0223
660 HEAD DISCOMFORT 394 0.0222
661 CELLULITIS 1117 0.0221
662 ANGIOEDEMA 978 0.0221
663 MUSCLE RIGIDITY 264 0.0221
664 INSOMNIA 5877 0.0220
665 RESTLESS LEGS SYNDROME 400 0.0220
666 VERTIGO 1336 0.0219
667 CEREBRAL HAEMORRHAGE 784 0.0219
668 METASTASES TO CENTRAL NERVOUS SYSTEM 282 0.0218
669 OFF LABEL USE 19112 0.0218
670 LIVER FUNCTION TEST ABNORMAL 633 0.0217
671 LABORATORY TEST ABNORMAL 642 0.0217
672 SARS-COV-2 TEST POSITIVE 287 0.0217
673 FEELING HOT 1332 0.0217
674 SPINAL FRACTURE 435 0.0217
675 HEADACHE 13606 0.0217
676 CHILLS 2542 0.0217
677 THROMBOSIS 1744 0.0217
678 ERUCTATION 419 0.0216
679 SWOLLEN TONGUE 676 0.0216
680 INTERSTITIAL LUNG DISEASE 1047 0.0216
681 COGNITIVE DISORDER 1006 0.0215
682 POOR QUALITY SLEEP 463 0.0215
683 PROCEDURAL PAIN 596 0.0215
684 RENAL DISORDER 1001 0.0215
685 HEAD INJURY 679 0.0214
686 DIABETES MELLITUS 1635 0.0214
687 POST PROCEDURAL HAEMORRHAGE 249 0.0214
688 COAGULOPATHY 356 0.0213
689 DRUG ERUPTION 378 0.0213
690 CHOKING 415 0.0213
691 HIP FRACTURE 684 0.0212
692 THROAT IRRITATION 954 0.0212
693 HYPERHIDROSIS 2736 0.0212
694 PNEUMOTHORAX 336 0.0212
695 QUALITY OF LIFE DECREASED 284 0.0211
696 VENTRICULAR FIBRILLATION 235 0.0211
697 MALAISE 9240 0.0210
698 SCRATCH 222 0.0210
699 INTENTIONAL DOSE OMISSION 599 0.0210
700 BLOOD URINE PRESENT 398 0.0209
701 ACUTE RESPIRATORY DISTRESS SYNDROME 370 0.0209
702 LYMPHADENOPATHY 740 0.0209
703 ATAXIA 247 0.0208
704 BRAIN FOG 326 0.0208
705 UVEITIS 281 0.0207
706 PLASMA CELL MYELOMA 808 0.0207
707 PULMONARY THROMBOSIS 225 0.0206
708 TOOTH DISORDER 458 0.0206
709 CARPAL TUNNEL SYNDROME 287 0.0205
710 PERIPHERAL COLDNESS 281 0.0204
711 POLLAKIURIA 853 0.0204
712 CHROMATURIA 460 0.0204
713 METASTASES TO LIVER 358 0.0203
714 RENAL FAILURE ACUTE 864 0.0203
715 DEPRESSION 4618 0.0203
716 BODY HEIGHT DECREASED 216 0.0202
717 DEMENTIA 564 0.0202
718 ANKLE FRACTURE 312 0.0201
719 PLATELET COUNT DECREASED 2148 0.0201
720 LUNG INFECTION 313 0.0201
721 GALLBLADDER DISORDER 358 0.0200
722 MYELODYSPLASTIC SYNDROME 290 0.0200
723 MUSCULOSKELETAL DISCOMFORT 345 0.0200
724 ILLNESS 2064 0.0200
725 TENDONITIS 310 0.0200
726 POST PROCEDURAL COMPLICATION 384 0.0200
727 PRODUCT ADMINISTRATION ERROR 404 0.0200
728 INITIAL INSOMNIA 205 0.0200
729 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3595 0.0199
730 NEOPLASM 229 0.0199
731 ANXIETY 5662 0.0199
732 MUSCLE ATROPHY 252 0.0199
733 DEEP VEIN THROMBOSIS 1287 0.0198
734 TOOTH FRACTURE 218 0.0198
735 DYSSTASIA 577 0.0197
736 MASS 276 0.0197
737 STEVENS-JOHNSON SYNDROME 439 0.0197
738 FLUID OVERLOAD 287 0.0197
739 DECREASED ACTIVITY 212 0.0196
740 FACE OEDEMA 331 0.0196
741 STAPHYLOCOCCAL INFECTION 647 0.0196
742 DIABETES MELLITUS INADEQUATE CONTROL 345 0.0195
743 BONE MARROW FAILURE 396 0.0195
744 PHARYNGITIS STREPTOCOCCAL 210 0.0194
745 SPEECH DISORDER 1008 0.0192
746 DERMATITIS CONTACT 219 0.0192
747 APHONIA 268 0.0192
748 PHOTOPHOBIA 361 0.0192
749 BALANCE DISORDER 1650 0.0191
750 SKIN REACTION 268 0.0190
751 VIRAL INFECTION 633 0.0190
752 CARDIAC FAILURE CONGESTIVE 1515 0.0188
753 UNRESPONSIVE TO STIMULI 486 0.0188
754 MULTI-ORGAN FAILURE 325 0.0188
755 FUNGAL INFECTION 626 0.0188
756 BRAIN OEDEMA 237 0.0187
757 GASTRIC DISORDER 642 0.0187
758 METASTASES TO BONE 307 0.0187
759 BONE PAIN 1095 0.0187
760 FRACTURE 353 0.0186
761 SWELLING FACE 1213 0.0186
762 THERAPEUTIC RESPONSE SHORTENED 617 0.0186
763 CARDIOVASCULAR DISORDER 469 0.0185
764 PRODUCT USE IN UNAPPROVED INDICATION 4573 0.0184
765 CYTOPENIA 225 0.0184
766 ACUTE MYELOID LEUKAEMIA 286 0.0183
767 LOSS OF CONSCIOUSNESS 2351 0.0183
768 COLD SWEAT 323 0.0183
769 TREMOR 3035 0.0183
770 HYPERSOMNIA 524 0.0183
771 INSURANCE ISSUE 279 0.0182
772 PAIN IN JAW 516 0.0182
773 CHOLECYSTECTOMY 208 0.0182
774 GENERALISED TONIC-CLONIC SEIZURE 301 0.0182
775 PALPITATIONS 2130 0.0182
776 HALLUCINATION 1363 0.0181
777 MENTAL STATUS CHANGES 502 0.0181
778 NEUROPATHY PERIPHERAL 1719 0.0181
779 WHITE BLOOD CELL COUNT DECREASED 1955 0.0180
780 EYE PAIN 1016 0.0180
781 TENDON RUPTURE 222 0.0180
782 FEMUR FRACTURE 555 0.0179
783 ORAL DISCOMFORT 247 0.0178
784 ERYTHEMA 3643 0.0177
785 MYALGIA 3007 0.0177
786 PERITONITIS 366 0.0177
787 NEUTROPHIL COUNT DECREASED 716 0.0175
788 VISUAL IMPAIRMENT 2173 0.0175
789 SEROTONIN SYNDROME 336 0.0175
790 ADVERSE DRUG REACTION 1571 0.0175
791 DRY EYE 873 0.0175
792 OSTEOMYELITIS 316 0.0174
793 MOVEMENT DISORDER 560 0.0174
794 RESPIRATORY DEPRESSION 213 0.0174
795 PSORIASIS 2261 0.0173
796 BRONCHOSPASM 247 0.0173
797 COMA 824 0.0173
798 DEPRESSED MOOD 912 0.0172
799 CARDIOMYOPATHY 254 0.0172
800 HOT FLUSH 1294 0.0172
801 SENSORY DISTURBANCE 275 0.0171
802 SPINAL OPERATION 211 0.0171
803 MALIGNANT MELANOMA 228 0.0170
804 ECZEMA 887 0.0169
805 CYANOSIS 266 0.0169
806 ECONOMIC PROBLEM 256 0.0169
807 HAEMORRHAGE INTRACRANIAL 252 0.0168
808 THYROID DISORDER 259 0.0168
809 GINGIVAL BLEEDING 229 0.0168
810 PROSTATIC SPECIFIC ANTIGEN INCREASED 231 0.0168
811 RASH MACULAR 583 0.0167
812 ADVERSE EVENT 1528 0.0166
813 DEPRESSED LEVEL OF CONSCIOUSNESS 654 0.0165
814 AGEUSIA 412 0.0165
815 GLAUCOMA 317 0.0164
816 BEDRIDDEN 216 0.0164
817 UPPER LIMB FRACTURE 327 0.0164
818 DIPLOPIA 426 0.0164
819 LACRIMATION INCREASED 494 0.0163
820 SKIN CANCER 350 0.0162
821 TOOTHACHE 293 0.0162
822 TINNITUS 743 0.0162
823 HYPOACUSIS 696 0.0162
824 LETHARGY 929 0.0161
825 ANHEDONIA 424 0.0161
826 NEOPLASM PROGRESSION 560 0.0161
827 THROAT TIGHTNESS 435 0.0161
828 HYPOAESTHESIA ORAL 242 0.0160
829 DISTURBANCE IN ATTENTION 865 0.0160
830 SOMNOLENCE 3228 0.0160
831 PRODUCT DOSE OMISSION IN ERROR 453 0.0160
832 CARDIAC ARREST 1320 0.0160
833 NEUROTOXICITY 278 0.0158
834 FEELING JITTERY 302 0.0158
835 IMMUNE SYSTEM DISORDER 208 0.0158
836 THERAPY INTERRUPTED 1127 0.0158
837 THIRST 281 0.0157
838 CARDIO-RESPIRATORY ARREST 655 0.0156
839 SCAR 268 0.0156
840 DELUSION 242 0.0156
841 MUSCLE TIGHTNESS 252 0.0155
842 HALLUCINATION, AUDITORY 246 0.0155
843 BONE DISORDER 282 0.0155
844 INFLUENZA LIKE ILLNESS 1269 0.0154
845 ALTERED STATE OF CONSCIOUSNESS 333 0.0154
846 CARDIAC DISORDER 1429 0.0153
847 SKIN FISSURES 298 0.0152
848 DYSKINESIA 617 0.0152
849 INTENTIONAL PRODUCT MISUSE 1329 0.0152
850 APATHY 220 0.0151
851 HOSPITALISATION 2317 0.0151
852 SKIN DISCOLOURATION 691 0.0150
853 SKIN DISORDER 497 0.0149
854 ANAPHYLACTIC SHOCK 384 0.0149
855 BLOOD TRIGLYCERIDES INCREASED 261 0.0148
856 MUSCULOSKELETAL DISORDER 281 0.0147
857 MALIGNANT NEOPLASM PROGRESSION 1502 0.0147
858 PANIC ATTACK 534 0.0146
859 BURNING SENSATION 1027 0.0146
860 PSYCHOMOTOR HYPERACTIVITY 242 0.0146
861 SHOCK 335 0.0146
862 SEIZURE 1649 0.0143
863 MULTIPLE FRACTURES 234 0.0142
864 LYMPHOMA 220 0.0142
865 THERAPEUTIC RESPONSE DECREASED 862 0.0142
866 DYSGEUSIA 1056 0.0142
867 COLON CANCER 210 0.0141
868 DISEASE PROGRESSION 1667 0.0141
869 CEREBROVASCULAR ACCIDENT 2372 0.0140
870 CYTOMEGALOVIRUS INFECTION 231 0.0139
871 ANAPHYLACTIC REACTION 766 0.0139
872 DISEASE RECURRENCE 659 0.0138
873 INCREASED APPETITE 264 0.0138
874 DEAFNESS 359 0.0137
875 TREATMENT NONCOMPLIANCE 751 0.0137
876 PARANOIA 235 0.0136
877 MENTAL DISORDER 589 0.0135
878 AGITATION 994 0.0135
879 MUSCLE TWITCHING 310 0.0134
880 BLOOD GLUCOSE ABNORMAL 248 0.0134
881 PRURITUS GENERALISED 290 0.0134
882 HAEMORRHAGE 1401 0.0134
883 MYOCARDIAL INFARCTION 2330 0.0133
884 DRUG INEFFECTIVE 17560 0.0133
885 UNDERDOSE 961 0.0132
886 SKIN EXFOLIATION 1109 0.0131
887 SUICIDE ATTEMPT 792 0.0130
888 GLYCOSYLATED HAEMOGLOBIN INCREASED 329 0.0130
889 EYE DISORDER 427 0.0130
890 PRODUCT DOSE OMISSION ISSUE 3808 0.0129
891 MENTAL IMPAIRMENT 311 0.0128
892 THERAPY CESSATION 658 0.0128
893 VISION BLURRED 1751 0.0127
894 NERVOUSNESS 665 0.0127
895 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 697 0.0127
896 LIP SWELLING 415 0.0124
897 SEDATION 325 0.0124
898 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 288 0.0123
899 DERMATITIS 258 0.0123
900 IMPAIRED WORK ABILITY 262 0.0122
901 PRODUCT DOSE OMISSION 796 0.0122
902 FEELING ABNORMAL 2913 0.0121
903 EYE SWELLING 445 0.0119
904 FLUSHING 1206 0.0119
905 PSYCHOTIC DISORDER 349 0.0118
906 EYE IRRITATION 680 0.0118
907 RASH PAPULAR 264 0.0118
908 PRODUCT AVAILABILITY ISSUE 268 0.0118
909 SURGERY 688 0.0117
910 BONE DENSITY DECREASED 363 0.0116
911 OCULAR HYPERAEMIA 543 0.0114
912 OSTEONECROSIS OF JAW 275 0.0111
913 DIABETIC KETOACIDOSIS 262 0.0109
914 FEAR 288 0.0107
915 AGGRESSION 533 0.0106
916 NERVOUS SYSTEM DISORDER 332 0.0106
917 SUICIDAL IDEATION 969 0.0106
918 INCORRECT PRODUCT ADMINISTRATION DURATION 229 0.0106
919 EYE PRURITUS 354 0.0105
920 UNEVALUABLE EVENT 795 0.0105
921 MOOD ALTERED 284 0.0104
922 DEATH 8866 0.0103
923 CEREBRAL INFARCTION 250 0.0102
924 DRY SKIN 1342 0.0100
925 TOXICITY TO VARIOUS AGENTS 1689 0.0100
926 PRODUCT SUBSTITUTION ISSUE 576 0.0100
927 CRYING 362 0.0100
928 NEOPLASM MALIGNANT 650 0.0097
929 NIGHTMARE 334 0.0096
930 BLOOD GLUCOSE INCREASED 1799 0.0095
931 ERECTILE DYSFUNCTION 243 0.0095
932 HEPATIC FUNCTION ABNORMAL 351 0.0094
933 BLINDNESS 381 0.0093
934 PAIN OF SKIN 249 0.0092
935 ACCIDENTAL OVERDOSE 337 0.0092
936 NEEDLE ISSUE 268 0.0092
937 RASH GENERALISED 236 0.0091
938 GASTRIC CANCER 229 0.0090
939 PREMATURE BABY 272 0.0090
940 OVERDOSE 1926 0.0089
941 BLOOD GLUCOSE DECREASED 416 0.0087
942 EMOTIONAL DISORDER 267 0.0087
943 MOOD SWINGS 274 0.0086
944 FOETAL EXPOSURE DURING PREGNANCY 696 0.0086
945 PRODUCT QUALITY ISSUE 1133 0.0083
946 LUNG NEOPLASM MALIGNANT 341 0.0083
947 RESPIRATORY ARREST 228 0.0083
948 OSTEONECROSIS 265 0.0081
949 VISUAL ACUITY REDUCED 266 0.0080
950 MULTIPLE SCLEROSIS 381 0.0080
951 INCORRECT DOSE ADMINISTERED 1789 0.0078
952 THERAPEUTIC RESPONSE UNEXPECTED 347 0.0077
953 INJECTION SITE BRUISING 616 0.0077
954 DRUG ABUSE 632 0.0076
955 PANCREATIC CARCINOMA 219 0.0076
956 INJECTION SITE MASS 278 0.0075
957 EMOTIONAL DISTRESS 910 0.0075
958 INTENTIONAL OVERDOSE 476 0.0074
959 MULTIPLE SCLEROSIS RELAPSE 506 0.0074
960 IRRITABILITY 433 0.0072
961 INJECTION SITE RASH 219 0.0071
962 DEVICE DISLOCATION 310 0.0071
963 DEVICE ISSUE 616 0.0069
964 INJECTION SITE PRURITUS 459 0.0068
965 INJECTION SITE SWELLING 524 0.0068
966 ANGER 231 0.0068
967 ABNORMAL BEHAVIOUR 269 0.0068
968 DRUG EFFECT INCOMPLETE 243 0.0067
969 WITHDRAWAL SYNDROME 279 0.0066
970 INJECTION SITE PAIN 2035 0.0066
971 ACNE 501 0.0066
972 MYELOSUPPRESSION 231 0.0064
973 COMPLETED SUICIDE 529 0.0063
974 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1250 0.0062
975 INJECTION SITE REACTION 419 0.0061
976 DRUG DOSE OMISSION 998 0.0060
977 INJECTION SITE ERYTHEMA 741 0.0060
978 CONVULSION 341 0.0060
979 DERMATITIS ATOPIC 300 0.0057
980 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 403 0.0057
981 INJECTION SITE HAEMORRHAGE 440 0.0055
982 VAGINAL HAEMORRHAGE 238 0.0055
983 DRUG EFFECT DECREASED 292 0.0054
984 EXTRA DOSE ADMINISTERED 209 0.0052
985 SKIN IRRITATION 232 0.0051
986 DEVICE MALFUNCTION 331 0.0047
987 SKIN BURNING SENSATION 287 0.0040
988 NO ADVERSE EVENT 721 0.0040
989 BREAST CANCER 362 0.0039
990 PROSTATE CANCER 301 0.0037
991 ACCIDENTAL EXPOSURE TO PRODUCT 304 0.0029
992 DRUG WITHDRAWAL SYNDROME 249 0.0028
993 PRODUCT STORAGE ERROR 246 0.0028
994 DRUG DEPENDENCE 392 0.0024